Literature DB >> 19614672

Co-treatment with deoxycholic acid and azoxymethane accelerates secretion of HMGB1 in IEC6 intestinal epithelial cells.

K Fujii1, Y Luo, T Sasahira, A Denda, H Ohmori, H Kuniyasu.   

Abstract

OBJECTIVES: High-mobility group box 1 (HMGB1) is a nuclear protein that acts as a ligand of the receptor for advanced glycation end products (RAGE) and its expression enhances progression of cancer. However, the mechanism underlying HMGB1 secretion is still unclear. In this study, we examined the effect of deoxycholic acid (DCA), a promoter of colon carcinogenesis, on HMGB1 secretion.
MATERIALS AND METHODS: We used an in vitro transformation model comprised of IEC6 intestinal epithelial cells treated with azoxymethane (AOM) and/or DCA. HMGB1 expression and secretion were examined by Western and Northern blot analyses, and ELISA. Intracellular translocation of HMGB1 was examined by protein fractionation.
RESULTS: AOM + DCA-treated IEC6 cells showed upregulation of HMGB1 mRNA expression and increased level of HMGB1 protein in culture medium, but decreased level of HMGB1 protein in the nucleus. AOM + DCA treatment increased level of histone H4 acetylation, which induced translocation of HMGB1 from the nucleus to the cytoplasm and increased HMGB1 secretion. Leptomycin B inhibited extranuclear translocation and secretion of the HMGB1 protein.
CONCLUSION: These findings suggest that DCA affects intracellular localization and secretion of HMGB1.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19614672      PMCID: PMC6495857          DOI: 10.1111/j.1365-2184.2009.00624.x

Source DB:  PubMed          Journal:  Cell Prolif        ISSN: 0960-7722            Impact factor:   6.831


  48 in total

1.  Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion.

Authors:  Tiziana Bonaldi; Fabio Talamo; Paola Scaffidi; Denise Ferrera; Annalisa Porto; Angela Bachi; Anna Rubartelli; Alessandra Agresti; Marco E Bianchi
Journal:  EMBO J       Date:  2003-10-15       Impact factor: 11.598

Review 2.  Dual roles for HMGB1: DNA binding and cytokine.

Authors:  C J Czura; H Wang; K J Tracey
Journal:  J Endotoxin Res       Date:  2001

Review 3.  HMG-1 rediscovered as a cytokine.

Authors:  H Yang; H Wang; K J Tracey
Journal:  Shock       Date:  2001-04       Impact factor: 3.454

4.  Inhibitory effect of linoleic acid on transformation of IEC6 intestinal cells by in vitro azoxymethane treatment.

Authors:  Takamitsu Sasaki; Kazuhiro Yoshida; Hideo Shimura; Masayosi Ichiba; Tomonori Sasahira; Takasumi Shimomoto; Ayumi Denda; Hiroki Kuniyasu
Journal:  Int J Cancer       Date:  2006-02-01       Impact factor: 7.396

5.  Expression of receptors for advanced glycation end-products (RAGE) is closely associated with the invasive and metastatic activity of gastric cancer.

Authors:  Hiroki Kuniyasu; Naohide Oue; Atsuko Wakikawa; Hideo Shigeishi; Norimasa Matsutani; Kazuya Kuraoka; Reiko Ito; Hiroshi Yokozaki; Wataru Yasui
Journal:  J Pathol       Date:  2002-02       Impact factor: 7.996

6.  The role of HMGB-1 on the development of necrosis during hepatic ischemia and hepatic ischemia/reperfusion injury in mice.

Authors:  Taiji Watanabe; Sunao Kubota; Masaki Nagaya; Shoichi Ozaki; Hiroko Nagafuchi; Katsuya Akashi; Yasuhiko Taira; Satoshi Tsukikawa; Shigeru Oowada; Suehiro Nakano
Journal:  J Surg Res       Date:  2005-03       Impact factor: 2.192

7.  Co-expression of receptor for advanced glycation end products and the ligand amphoterin associates closely with metastasis of colorectal cancer.

Authors:  Hiroki Kuniyasu; Yoshitomo Chihara; Tadateru Takahashi
Journal:  Oncol Rep       Date:  2003 Mar-Apr       Impact factor: 3.906

8.  Depletion of tumor-infiltrating macrophages is associated with amphoterin expression in colon cancer.

Authors:  Hiroki Kuniyasu; Takamitsu Sasaki; Tomonori Sasahira; Hitoshi Ohmori; Tadateru Takahashi
Journal:  Pathobiology       Date:  2004       Impact factor: 4.342

9.  Receptor for advanced glycation end products (RAGE) is important in the prediction of recurrence in human oral squamous cell carcinoma.

Authors:  T Sasahira; T Kirita; U K Bhawal; K Yamamoto; H Ohmori; K Fujii; H Kuniyasu
Journal:  Histopathology       Date:  2007-06-25       Impact factor: 5.087

Review 10.  Amphoterin as an extracellular regulator of cell motility: from discovery to disease.

Authors:  H J Huttunen; H Rauvala
Journal:  J Intern Med       Date:  2004-03       Impact factor: 8.989

View more
  6 in total

1.  Significance of epithelial growth factor in the epithelial-mesenchymal transition of human gallbladder cancer cells.

Authors:  Takamitsu Sasaki; Hiroki Kuniyasu; Yi Luo; Daisuke Kato; Satoshi Shinya; Kiyomu Fujii; Hitoshi Ohmori; Yuichi Yamashita
Journal:  Cancer Sci       Date:  2012-04-03       Impact factor: 6.716

2.  Metformin inhibits HMGB1 release in LPS-treated RAW 264.7 cells and increases survival rate of endotoxaemic mice.

Authors:  Konstantin Tsoyi; Hwa Jin Jang; Irina Tsoy Nizamutdinova; Young Min Kim; Young Soo Lee; Hye Jung Kim; Han Geuk Seo; Jae Heun Lee; Ki Churl Chang
Journal:  Br J Pharmacol       Date:  2011-04       Impact factor: 8.739

3.  Endotoxin tolerance alleviates experimental acute liver failure via inhibition of high mobility group box 1.

Authors:  Nai-Bin Yang; Shun-Lan Ni; Shan-Shan Li; Sai-Nan Zhang; Dan-Ping Hu; Ming-Qin Lu
Journal:  Int J Clin Exp Pathol       Date:  2015-08-01

4.  High mobility group box 1 release from hepatocytes during ischemia and reperfusion injury is mediated by decreased histone deacetylase activity.

Authors:  John Evankovich; Sung W Cho; Ruilin Zhang; Jon Cardinal; Rajeev Dhupar; Lemeng Zhang; John R Klune; Jason Zlotnicki; Timothy Billiar; Allan Tsung
Journal:  J Biol Chem       Date:  2010-10-11       Impact factor: 5.157

5.  Oxidized high mobility group B-1 enhances metastability of colorectal cancer via modification of mesenchymal stem/stromal cells.

Authors:  Shingo Kishi; Rina Fujiwara-Tani; Kanya Honoki; Rika Sasaki; Shiori Mori; Hitoshi Ohmori; Takamitsu Sasaki; Yoshihiro Miyagawa; Isao Kawahara; Akira Kido; Yasuhito Tanaka; Hiroki Kuniyasu
Journal:  Cancer Sci       Date:  2022-05-23       Impact factor: 6.518

6.  The association of HMGB1 expression with clinicopathological significance and prognosis in Asian patients with colorectal carcinoma: a meta-analysis and literature review.

Authors:  Xiaoli Zhang; Jinming Yu; Minghuan Li; Hui Zhu; Xindong Sun; Li Kong
Journal:  Onco Targets Ther       Date:  2016-08-08       Impact factor: 4.147

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.